Reprocell Europe Limited

no public description

"Since their discovery in 2006, induced pluripotent stem cells (iPSC) have demonstrated their importance to disease modelling, drug discovery and regenerative medicine. Using genes/transcription factors associated with embryonic maintenance, 'adult' somatic cells are reprogrammed or induced to an embryonic-like state. This creates cells with the propertie...

Alcyomics have developed unique, non-animal, non-artificial human skin explant assays (Skimune™ and Skimune™3D) which can test for safety and efficacy of novel drugs and compounds, including cosmetics. Alcyomics assays enable the products of the pharmacuetical, chemical and cosmetics industries to reach the clinic and/or the market place, quicker by early...

Biopta sources fresh human tissue through ethical routes and uses them to study the action of potential new medicines. It performs these studies for drug companies and for and in collaboraton with academic and NHS partners. This provides an invaluable source of data to help understand and improve existing therapies. But Biopta can and wants to do more. Th...

Awaiting Public Project Summary

The pharmaceutical industry is in urgent need of tests that are better able to predict the clinical effectiveness and safety of new drug therapies. Current approaches are over-reliant on animal models that may not reflect human responses to drugs and often do not select drugs that translate into safe, effective treatment of diseases. Indeed around 90% of ...